Similar articles

• Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.

  Aggermann T, Stolba U, Brunner S, Binder S. Aggermann T, et al. Ophthalmologica. 2006;220(2):131-3. doi: 10.1159/000090579. Ophthalmologica. 2006. PMID: 16491037
• Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.

  Amato JE, Lee DH, Santos BA, Akduman L. Amato JE, et al. Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):245-7. doi: 10.1080/09273940590928562. Ocul Immunol Inflamm. 2005. PMID: 16019686
• Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.

  Krepler K, Ergun E, Sacu S, Richter-Müksch S, Wagner J, Stur M, Wedrich A. Krepler K, et al. Acta Ophthalmol Scand. 2005 Feb;83(1):71-5. doi: 10.1111/j.1600-0420.2005.00400.x. Acta Ophthalmol Scand. 2005. PMID: 15715561
• Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

  Jonas JB. Jonas JB. Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
• [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].

  Jonas JB, Kreissig I, Degenring RF. Jonas JB, et al. Klin Monbl Augenheilkd. 2003 Jun;220(6):384-90. doi: 10.1055/s-2003-40272. Klin Monbl Augenheilkd. 2003. PMID: 12830391 Review. German.